Zuletzt aktualisiert: 09.11.2026, 00:00

UBS(Lux)Fund Solutions – FTSE 100 UCITS ETF(GBP)A-dis CHF Exchange (SW, CHF)

100GBA.SW

106.64
-4.16 (-3.75%)
SW
Heute investieren
Heute investieren
1 Jahr Rückkehr (CAGR)
12.70%
3-Jahres-Rendite (CAGR)
-
5-Jahres-Rendite (CAGR)
-
10-Jahres-Rendite (CAGR)
-
Aktienanalyse

Adobe 2026 Q3 – Wird der Preis von der Stimmungslage bestimmt?

Mehr lesen
Marketcap
-
Preis/Umsatz
-
Ent-Wert
-
Preis/Buch
-
Div-Ertrag
0.00%
Wachstumsjahre
-
Div Wachstum
-
FCF-Ausschüttung
-
Nachlaufendes KGV
-
PEG
-
Forward P/E
-
EPS-Wachstum
-

Bestandsinformationen

iO Charts Blog

Was ist eine Börse? Funktionsweise, Akteure, Beispiele

Mehr lesen

Aktienchart

Loading...
Daten zum Aktienkurs
Öffnen Sie106.64
Tageshöchststand106.64
Tägliches Tief106.64
Tägliches Volumen0K
Allzeithoch163.75
1-Jahres-Analystenschätzung-
Beta-
EPS (TTM)-
Dividende je Aktie0.00
Ex-Div-Datum13 Aug 2026
Nächstes Ergebnisdatum-

Bereit, das Wachstumspotenzial von UBS(Lux)Fund Solutions – FTSE 100 UCITS ETF(GBP)A-dis CHF zu nutzen?

Machen Sie den nächsten Schritt in Ihrem Portfolio.

Heute investieren

Nachteiliges Potenzial

Loading...
Nachteilige potenzielle Daten
100GBA.SWS&P500
Aktueller Preisrückgang vom Allzeithoch-34.88%-5.62%
Höchster Preisrückgang-53.18%-56.47%
Datum des höchsten Rückgangs9 Apr 20259 Mar 2009
Durchschnittlicher Rückgang vom Höchststand-41.53%-10.64%
Durchschnittliche Zeit bis zum neuen Höchststand-12 days
Maximale Zeit bis zum neuen Höchststand518 days1805 days
News
LLY, NVS and BAYRY stand out as the pharma sector rebounds in 2026, supported by innovative drug pipelines, strong product demand and rising earnings estimates.
10. November 2026
The European stock markets closed higher in Monday trading amid easing bond yields and oil prices, f
9. November 2026
Press release - Regulated Information Melexis: update on the share buy-back program Ieper, Belgium – 9 November 2026, 17.45 hrs CET Melexis reports the purchase of 28,100 Melexis shares on Euronext Br...
9. November 2026
In the Large-Cap Pharmaceuticals industry, LLY, NVS and BAYRY are worth watching as the industry shows a strong recovery.
9. November 2026
Novartis (NVS) will discontinue development of its experimental drug, pelacarsen, for atheroscleroti
9. November 2026
Alerion Clean Power has seen its share price move around in recent years, and that leaves investors asking a simple question. Does the current €18.38 price tag line up with what the business is earnin...
8. November 2026
Spadel has delivered a strong share price run over the past few years, and that kind of move naturally raises a question for you as an investor. Is the current price around €340 really in line with wh...
8. November 2026
Why the new Astroscale agreement matters for OHB OHB (XTRA:OHB) just signed a Memorandum of Understanding with Astroscale Holdings that targets joint work in space security, space domain awareness, an...
8. November 2026
Norwegian Air Shuttle (OB:NAS) is back in focus after Barclays upgraded the stock, citing lower spot and forward fuel prices along with a stronger sector outlook for airlines. Recent trading reflects ...
8. November 2026
Electrification is moving from climate slogan to policy to-do list, and potential COP31 commitments on cleaner power and transport could put EV charging networks on the front line. That shift matters ...
8. November 2026